Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fibrinolytic therapy in acute myocardial infarction: time to treatment in Canada.
Davies C, Christenson J, Campbell A, Cox JL, Huynh T, Matheson S, Daly PA, Hilbe J; FASTRAK II Network. Davies C, et al. Can J Cardiol. 2004 Jun;20(8):801-5. Can J Cardiol. 2004. PMID: 15229762 Clinical Trial.
Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
Huynh T, Cox JL, Massel D, Davies C, Hilbe J, Warnica W, Daly PA; FASTRAK II Network. Huynh T, et al. Am Heart J. 2004 Jul;148(1):86-91. doi: 10.1016/j.ahj.2004.02.006. Am Heart J. 2004. PMID: 15215796 Clinical Trial.
Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft.
Fyfe A, Daly P, Galligan L, Pirc L, Feindel C, Cardella C. Fyfe A, et al. J Am Coll Cardiol. 1993 Jan;21(1):171-6. doi: 10.1016/0735-1097(93)90733-h. J Am Coll Cardiol. 1993. PMID: 8417059
Cardiac transplantation for Fabry's disease.
Cantor WJ, Daly P, Iwanochko M, Clarke JT, Cusimano RJ, Butany J. Cantor WJ, et al. Can J Cardiol. 1998 Jan;14(1):81-4. Can J Cardiol. 1998. PMID: 9487277
Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries.
Clausell N, Butany J, Molossi S, Lonn E, Gladstone P, Rabinovitch M, Daly PA. Clausell N, et al. J Am Coll Cardiol. 1995 Jul;26(1):110-9. doi: 10.1016/0735-1097(95)00134-l. J Am Coll Cardiol. 1995. PMID: 7541058
Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.
Armstrong PW, Baigrie RS, Daly PA, Haq A, Gent M, Roberts RS, Freeman MR, Burns R, Liu P, Morgan CD. Armstrong PW, et al. J Am Coll Cardiol. 1989 Jun;13(7):1469-76. doi: 10.1016/0735-1097(89)90334-3. J Am Coll Cardiol. 1989. PMID: 2498414 Clinical Trial.
The efficacy and safety of recombinant tissue plasminogen activator (rt-PA) administered on a dosing per weight basis was evaluated in a randomized, placebo-controlled, double-blind trial in 115 patients with acute myocardial infarction. ...Early patency of the infarct-rel …
The efficacy and safety of recombinant tissue plasminogen activator (rt-PA) administered on a dosing per weight basis was evaluated i …
121 results
Jump to page
Feedback